These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7526097)

  • 1. Heparin-induced thrombocytopenia and antithrombotic therapy.
    Boon DM; Michiels JJ; Stibbe J; van Vliet HH; Kappers-Klunne MC
    Lancet; 1994 Nov; 344(8932):1296. PubMed ID: 7526097
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of heparin-induced thrombocytopenia.
    Peters FP
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):517-8. PubMed ID: 9305220
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.
    Lubenow N; Greinacher A
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():47-57. PubMed ID: 11155194
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
    Rice L; Nguyen PH; Vann AR
    Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy.
    Gill J; Kovacs MJ
    Obstet Gynecol; 1997 Oct; 90(4 Pt 2):648-50. PubMed ID: 11770579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
    Darling K; Jaumotte C; Saussoy P; Zech F; Lavenne E; Hainaut P
    Acta Clin Belg; 2000; 55(3):176-81. PubMed ID: 10981327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.
    Jackson MR; Danby CA; Alving BM
    Ann Thorac Surg; 1997 Dec; 64(6):1815-7. PubMed ID: 9436582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
    Hale LP; Smith K; Braden GA; Owen J
    Cathet Cardiovasc Diagn; 1998 Nov; 45(3):318-22. PubMed ID: 9829897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
    Lindhoff-Last E; Bauersachs R
    Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia and its treatment.
    Warkentin TE
    J Thromb Thrombolysis; 2000 Jun; 9 Suppl 1():S29-35. PubMed ID: 10859582
    [No Abstract]   [Full Text] [Related]  

  • 11. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
    Fischer KG
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.
    Tardy/Poncet B; Mahul P; Beraud AM; Favre JP; Tardy B; Guyotat D
    Br J Haematol; 1995 Aug; 90(4):969-70. PubMed ID: 7669684
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
    Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
    Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombocytopenia due to heparin therapy. Use of danaparoid (Orgaran), 13 monocentric cases under authorization of temporary prescription (ATU)].
    Gindre L; de Maistre E; Perrin A; Lecompte T; Hoffman MA
    Therapie; 1997; 52(6):591-7. PubMed ID: 9734113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: pathophysiology and management.
    Mureebe L; Silver D
    Vasc Endovascular Surg; 2002; 36(3):163-70. PubMed ID: 12075381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
    Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
    Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Olin DA; Urdaneta F; Lobato EB
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
    [No Abstract]   [Full Text] [Related]  

  • 19. Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
    Woo YL; Allard S; Cohen H; Letsky E; de Swiet M
    BJOG; 2002 Apr; 109(4):466-8. PubMed ID: 12013171
    [No Abstract]   [Full Text] [Related]  

  • 20. [Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].
    Christin F; Theissen-Laval O; Loeb JP
    Ann Fr Anesth Reanim; 1998; 17(1):82-3. PubMed ID: 9750692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.